Publications by authors named "Alan Zimmermann"

Claim this Profile
B
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).
Katherine R Tuttle, Mark C Lakshmanan, Brian Rayner, Alan G Zimmermann, Brad Woodward

Diabetes Obes Metab· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program.
Christopher J Child, Alan G Zimmermann, George P Chrousos, Elisabeth Cummings, Cheri L Deal

J Clin Endocrinol Metab· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 receptor agonists, CKD, and eGFR trajectory - Authors' reply.
Katherine R Tuttle, Mark C Lakshmanan, Brian Rayner, Robert S Busch, Alan G Zimmermann

Lancet Diabetes Endocrinol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes.
Werner F Blum, Jürgen Klammt, Serge Amselem, Heike M Pfäffle, Marie Legendre, Alan G Zimmermann

EBioMedicine· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Katherine R Tuttle, Mark C Lakshmanan, Brian Rayner, Robert S Busch, Alan G Zimmermann

Lancet Diabetes Endocrinol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study.
Charmian A Quigley, Christopher J Child, Alan G Zimmermann, Ron G Rosenfeld, Leslie L Robison

J Clin Endocrinol Metab· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.
Imane Benabbad, Myriam Rosilio, Christopher J Child, Jean-Claude Carel, Judith L Ross, Alan G Zimmermann

Horm Res Paediatr· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Primary Cancer Incidence in Growth Hormone-Treated Children: Comparison of a Multinational Prospective Observational Study with Population Databases.
Christopher J Child, Alan G Zimmermann, Nan Jia, Leslie L Robison, Jürgen H Brämswig

Horm Res Paediatr· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological Features in Patients with Short Stature Homeobox-Containing (SHOX) Gene Deficiency and Turner Syndrome before and after 2 Years of GH Treatment.
Christopher J Child, Gabriel Kalifa, Christine Jones, Judith L Ross, Gudrun A Rappold, Alan G Zimmermann

Horm Res Paediatr· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes.
Christopher J Child, Werner F Blum, Cheri Deal, Alan G Zimmermann, Charmian A Quigley

Eur J Endocrinol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).
Francesco Giorgino, Marian Benroubi, Jui-Hung Sun, Alan G Zimmermann, Valeria Pechtner

Diabetes Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
Christopher J Child, Daniel Conroy, Alan G Zimmermann, Whitney W Woodmansee, Eva Marie Erfurth

Eur J Endocrinol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safe and Effective Use of the Once Weekly Dulaglutide Single-Dose Pen in Injection-Naïve Patients With Type 2 Diabetes.
Glenn Matfin, Kate Van Brunt, Alan G Zimmermann, Rebecca Threlkeld, Debra A Ignaut

J Diabetes Sci Technol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical field study of the safety and efficacy of spinosad chewable tablets for controlling fleas on dogs.
Carol Robertson-Plouch, Keith A Baker, Rebecca R Hozak, Alan G Zimmermann, S Craig Parks

Vet Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between pituitary imaging abnormalities and clinical and biochemical phenotypes in children with congenital growth hormone deficiency: data from an international observational study.
Cheri Deal, Caroline Hasselmann, Roland W Pfäffle, Alan G Zimmermann, Charmian A Quigley

Horm Res Paediatr· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency.
Werner F Blum, Cheri Deal, Alan G Zimmermann, Elena P Shavrikova, Christopher J Child

Eur J Endocrinol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
Werner F Blum, Judith L Ross, Alan G Zimmermann, Charmian A Quigley, Christopher J Child

J Clin Endocrinol Metab· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS.
Whitney W Woodmansee, Alan G Zimmermann, Christopher J Child, Qi Rong, Eva Marie Erfurth

Eur J Endocrinol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.
Mark L Hartman, Rong Xu, Brenda J Crowe, Leslie L Robison, Eva Marie Erfurth, Alan G Zimmermann

J Clin Endocrinol Metab· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study.
Christopher J Child, Alan G Zimmermann, Whitney W Woodmansee, Daniel M Green, Jian J Li

Eur J Endocrinol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program.
Christopher J Child, Alan G Zimmermann, Robin S Scott, Gordon B Cutler, Tadej Battelino

J Clin Endocrinol Metab· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of orally administered spinosad (Comfortis) in dogs on adult and immature stages of the cat flea (Ctenocephalides felis).
Byron L Blagburn, David R Young, Columba Moran, Jeffery A Meyer, Anna Leigh-Heffron, Alan G Zimmermann

Vet Parasitol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.
Susan M Webb, Daojun Mo, Steven W J Lamberts, Shlomo Melmed, Francesco Cavagnini, Alan G Zimmermann

J Clin Endocrinol Metab· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Andrea F Attanasio, Daojun Mo, Eva Marie Erfurth, Meng Tan, Ken Y Ho, Alan G Zimmermann

J Clin Endocrinol Metab· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs.
Mami Irimajiri, Andrew U Luescher, Genefer Douglass, Carol Robertson-Plouch, Alan Zimmermann

J Am Vet Med Assoc· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis